QX

Serial Number 97411755
602

Registration Progress

Application Filed
May 16, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

QX

Basic Information

Serial Number
97411755
Filing Date
May 16, 2022
Abandonment Date
November 8, 2024
Drawing Code
5

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Nov 19, 2024
Classes
010

Rights Holder

MIVI Neuroscience, Inc.

03
Address
6545 City West Parkway
Eden Prairie, MN 55344

Ownership History

MIVI Neuroscience, Inc.

Original Applicant
03
Eden Prairie, MN

Legal Representation

Attorney
WILLIAM E. ANDERSON

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description Documents
Nov 19, 2024 EXPT T EXPARTE APPEAL TERMINATED Loading...
Nov 19, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Nov 19, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Aug 7, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 7, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2024 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Apr 5, 2024 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Apr 5, 2024 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Apr 4, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 4, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jan 4, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Oct 4, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 4, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 4, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Sep 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 14, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 31, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 14, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jun 14, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Mar 14, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 14, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 14, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 17, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 16, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 16, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 16, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 16, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 16, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 13, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
May 23, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 19, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Aspiration catheter for use in treating or diagnosing ischemic stroke; aspiration catheters for use in the removal of fresh, soft emboli and thrombi in the peripheral and neurovascular systems; aspiration catheters for use in the treatment and prevention of cerebrovascular accidents, thrombus, and vascular issues and conditions; aspiration catheters for use in radiology, neuroradiology, cardiology and surgery, for treating cerebrovascular accidents and removing clots and foreign bodies; catheters

Additional Information

Design Mark
The mark consists of the letters "QX" in which "X" is a changeable element referring to catheter size and consisting of the numerical designations of 3, 4, 5 or 6.

Classification

International Classes
010